4
Changes in Ownership
Damora Therapeutics, Inc. Filed Acc 0001209191-22-002215
Options or other derivatives
- Chief Executive Officer acquired 287,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Schambye Hans T. Chief Executive Officer | 2022-01-04 | Grant or award · Stock Option (right to buy) | +287,500 | 287,500 | D | ||
Loading xslF345X03/doc4.xml…